For three days, from 9 to 11 October, more than 300 scientists from over 20 countries met at the Haus der Wirtschaft in Stuttgart to discuss the current state of research, the latest product developments and therapies for clinical application in regenerative medicine and stem cell research. For the third time, BioStar 2008, a Congress on Regenerative Biology and Medicine – on this occasion in cooperation with the 3rd Annual Congress of the German Society for Stem Cell Research – offered its international audience a unique platform for exchanging information on an interdisciplinary basis.

The press conference held by BioRegio STERN Management GmbH at the opening of the 3rd Congress on Regenerative Biology and Medicine ­
BioStar 2008 and the 3rd Congress of the German Society for Stem Cell Research on October 9 was dominated by the sensational research results
published only shortly beforehand by Prof. Thomas Skutella, Director of the Center for Regenerative Biology and Medicine (ZRM) at University Hospital
Tübingen, Germany.

A team of researchers headed by Thomas Skutella, director of the Center for Regenerative Biology and Medicine, has made a major breakthrough in stem cell research. This week, the scientists in Tübingen, with first author Sabine Conrad and in cooperation with colleagues from the University Department of Urology, director Prof. Arnulf Stenzl, present their study on isolating pluripotent human stem cells in the renowned science journal “Nature”, providing a true alternative to ethically controversial embryonic stem cells.

immatics biotechnologies GmbH is pleased to announce that it has won the second prize in the European Biotechnica Award 2008.

Further success for STERN – “Science2Start” project gets underway

The “3rd Congress on Regenerative Biology and Medicine – BioStar 2008“ and the 3rd Congress of the German Society for Stem Cell Research will take place from October 9–11, 2008 in Stuttgart. The congress and the scientific meeting offer their international professional audience an excellent agenda ranging from basic research through to product development and clinical applications, covering numerous aspects of regenerative medicine and stem cell research.

When Alfred Nordheim studied biology in Berlin in the 1970s, Germany lagged far behind in comparison with the rest of the world when it came to genetics. Maybe one of the reasons the young Hessian student from Philippsthal decided nevertheless on molecular biology was that he had already spent 2 semesters studying aerospace engineering. “I had been concentrating on the basics of natural sciences such as physics and chemistry so I began approaching biology from an analytical point of view,” explains Prof. Nordheim who has been president of the German Genetics Society since 2005. In July of this year, Nordheim was elected as president of the International Genetics Federation during the International Congress of Genetics in Berlin. In Prof. Nordheim’s view, the fact that the congress took place in Germany means that the country has caught up in the field of genetics and is now eye to eye with leading international competitors.

The “3rd Congress on Regenerative Biology and Medicine – BioStar 2008“ and the 3rd Congress of the German Society for Stem Cell Research in October in Stuttgart.